Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss without scarring is more common than permanent hair loss with scarring, and is often due to genetic factors.

PCOS increases sexual pain and distress in infertile Iranian women.

PCOS causes sexual dysfunction, needing comprehensive treatment.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Hair loss in alopecia areata can negatively affect sexual quality of life.

5α-reductase inhibitors for hair loss can cause mild, reversible sexual side effects in some men.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Flibanserin shows promise for treating male sexual dysfunction but has side effects like insomnia and fatigue.

Women with PCOS are more likely to experience sexual dysfunction, but lifestyle changes and weight loss can improve sexual function.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Finasteride for hair loss may cause erectile dysfunction due to tissue fibrosis, and various factors contribute to female sexual dysfunction.

Telemedicine is effective for sexual medicine consultations.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Dutasteride is more effective than finasteride for hair growth with similar side effects.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Male mice with FGF5 mutations grow longer hair than females.

The meeting highlighted advances in sexual medicine and priapism management.

Finasteride effectively treats baldness but may cause sexual side effects.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.